Applications Published 5 September 2001
Published: 17-May-2002
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
Utilisation of cation-active mixtures
Cognis Deutschland 1128808*Aqueous ophthlamic formulations comprising chitosan
Laboratoires Medidom 1128809*Drug delivery device, especially for the delivery of androgens
Leiras 1128810*Drug delivery device, especially for the delivery of progestins and estrogens
Leiras 1128811*Nano-emulsion of 5-aminolevulinic acid
Asat AG Applied Science & Technology 1128812*An inhalation system
Pilkiewicz, Frank 1128813*Aerosols comprising nanoparticle drugs
Elan Phnarmaceuticals 1128814*Process for preparing oral calcium compsns
Nycomed Pharma 1128815*Polyvinyl alcohol micropheres and methods for making and therapeutic uses of the same
Biosphere Medical 1128816*Microparticles containing PEG and/or PEG glyceryl esters
Bioval Technologies 1128817*Functrionalised nanocrystals and their use in detection systems
Biocrystal 1128818*New controlled release bead, a method of producing the same and multiple unit formulation comprising it
Pharmacia 1128819*Pharmaceutical mixture comprising a combination of a protein and other active compounds
Knoll 1128820*A capsule based drug delivery system
Bioprogress Technology International 1128821*Antioxidant compsn comrpising propionyl L-carnitine and a flavonoid against thrombosis and atherosclerosis
Sigma-Tau Healthscience 1128822*Use of propionyl L-carnitine for the preparation of a medicament capable of inducing apoptosis
Sigma-Tau Healthscience 1128823*Ionic silver complex
Newman, Ira Jay; Washburn, David 1128824*A new compsn
AstraZeneca 1128825* Chromone enteric release formulation
Hewlett Healthcare 1128826*Pharmaceutical comps for modified release insulin sensitiser
SmithKline Beecham 1128827*Riluzol and alpha-tocopherol combination
Aventis 1128829*Reversing advanced glycosylation cross-links using heterocyclic-substituted thiazolium salts
Alteon 1128830*Pharmaceutical moxifloxacin preparation
Bayer 1128831*Compounds, compsns and methods for treating or preventing viral infections and associated diseases
Viropharma Inc 1128832*Use of agonists of glucocorticosteroid receptors and/or mineral corticosteroid receptors, especially corticosteroids to treat addictions
Medimod Research Institute 1128833*Combinations for diabetes which contain a sulphonylurea, a glitazone and abiguanide
Warner-Lambert 1128834*Cyanocobalamin (vitamin B12) treatment in allergic disease
Allergy Ltd 1128835*In utero transplantation of human mesenchymal stem cells
Osiris Therapeutics 1128836*Method for preventing and reversing athersclerosis in mammals
Vasogen Ireland 1128837*A method for inducing or enhancing chrondrogenesis with extracellular matrix containing GDF-5
Orquest 1128838*Pharmaceutical compsn comprising peptide copolymers and methods for preventing and treating GVHD and HVGD
Yeda Research and Development Company 1128837*Prevention of muscle mass loss with leptin receptor ligands
Eli Lilly 1128840*Pharmaceutical preparation containing a receptor-antagonist for treating blood clotting disorders
Baxter AG 1128841*Method of treating heparin-induced thrombocytopenia
Eli Lilly 1128842*Vaccine against papillatomous digital dermatitis (DDP)
The Regents of the University of California 1128843*Methods for enhancing wound healing
Mayo Foundation for Medical Education 1128844*Combinations comprising a beta-agonist and a further antidiabetic agent
SmithKline Beecham 1128845*Shear thickening pregelatinised starch
Avebe America 1128846*Antibody-serum protein hybrids
Celltech Therapeutics 1128847*A novel method of diagnosing, monitoring, staging and treating gynecological and prostatic cancer
diaDexus 1128848*Method for producing cyclohexanediamines
Lonza 1129063*Method for preparing tris(ether-amine)
Rhodia Chimie 1129065*Bicyclic signal transduction inhibitors, compsn containing them and uses thereof
Ariad Pharmaceuticals 1129068*Method for the crystallisation of iopamidol
Dong Kook Pharmaceuticals 1129069*Neurotrophic and carbamate agents
Bristol-Myers Squibb 1129070*Phenyl-substituted cyclic enaminones
Bayer 1129071*N-substituted azacycles, their preparation and their use as ORL-1 receptor ligands
SmithKline Beecham 1129072*Process and intermediates for production of donepezil and related compounds
Finetech 1129073*Anthralinic acid amides and the use thereof as medicaments
Schering 1129074*N-aryl(thio)anthralinic acid amide derivatives, their preparation and their use as VEGF receptor tyrosine kinase inhibitors
Novartis 1129075*